DAWN

NASDAQStock

Day One Biopharmaceuticals, Inc.

$21.27+0.01 (+0.07%)

52-Week Range

$5.80
$21.33

Key Stats

Market Cap

2.2B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

-1.25

Volume

7.0M

Avg Volume

10.1M

Performance

1M

+89.40%

3M

+157.19%

6M

+196.24%

YTD

+140.34%

1Y

+144.48%

3Y

+12.42%

5Y

-17.84%

Price Chart

ETF Exposure

DAWN is held by 68 ETFs

ETFFund NameWeight
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
AVUSAvantis U.S. Equity ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About DAWN ETF Exposure

Day One Biopharmaceuticals, Inc. (DAWN) is held by 68 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.2B, DAWN is a widely held institutional stock. The stock currently trades at $21.27. Investors can gain exposure to DAWN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold DAWN, sorted by portfolio weight.